ENTX
Entera Bio Ltd
2.90$
-1.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | -1,959.2% | -3,779.2% | -2,892.3% | -1,587.2% | -9,327.6% | -52,214.3% | -3,766.9% | -17,547.6% | |
| – | – | – | 10.8% | 100.8% | 17.3% | 9.3% | 47.8% | 400.0% | 25.4% | 71.4% | |
| – | – | – | 246.6% | 628.4% | 246.8% | 325.9% | 1,676.9% | 12,064.3% | 1,412.2% | 6,547.6% | |
| – | – | – | 138.0% | 331.8% | -86.0% | 291.1% | 1,748.5% | – | – | – | |
| – | – | – | -101.2% | 292.8% | -96.2% | 246.8% | -1,369.4% | -1,392.9% | 61.9% | 2,992.9% | |
| – | – | – | 13.6% | 16.9% | 14.5% | 3.0% | 35.1% | 121.4% | 1.7% | 254.8% | |
| – | – | – | -813.6% | 1,672.0% | -14.5% | -3.0% | -76.1% | -121.4% | -1.7% | -254.8% | |
| – | – | – | 1,924.8% | 5,409.3% | – | – | – | – | – | – | |
| – | – | – | -22.8% | -48.3% | -37.3% | – | – | – | – | – | |
| – | – | – | 1,924.8% | 5,361.0% | 1,109.9% | 4,445.0% | 9.7% | 43,114.3% | 2,472.9% | 32,642.9% | |
| – | – | – | -848.0% | 3,253.8% | -1,797.0% | 2,854.8% | -9,390.3% | -9,221.4% | -1,295.6% | 14,840.5% | |
| – | – | – | -1,972.8% | -3,796.2% | -2,906.8% | -1,590.2% | -9,362.7% | -52,335.7% | -3,768.5% | -17,802.4% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.